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Envenomation by the spider Loxosceles can result in dermonecrosis and severe ulceration. Our aim was to in-
vestigate the role of the complement system and of the endogenous metalloproteinases in the initiation of the
pathology of dermonecrosis. Histological analysis of skin of rabbits injected with Loxosceles intermedia venom
and puriﬁed or recombinant sphingomyelinases showed a large inﬂux of neutrophils, concomitant with dissoci-
ation of the collagenous ﬁbers in the dermis. Decomplementation, using cobra venom factor, largely prevented the
inﬂux of neutrophils, while inﬂux of neutrophils was also reduced in genetically C6-deﬁcient rabbits, suggesting
roles for both C5a and the membrane attack complex in the induction of dermonecrosis. However, C-depletion and
C6 deﬁciency did not prevent the haemorrhage and the collagen injury. Zymography analysis of skin extracts
showed the induction of expression of the endogenous gelatinase MMP-9 in the skin of envenomated animals.
Rabbit neutrophils contained high levels of MMP-9, expression of which was further increased after incubation with
venom, suggesting that these cells may be a source of the MMP-9 found in the skin of envenomated animals.
Furthermore, skin ﬁbroblasts also secreted MMP-9 and MMP-2 upon incubation with venom, suggesting that locally
produced MMPs can also contribute to proteolytic tissue destruction.
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Envenomation by arachnids of the genus Loxosceles (brown
spider), found in temperate and tropical regions of America,
Africa, and Europe, commonly results in disfiguring necrotic
skin lesions (Wasserman and Anderson, 1983–1984). At
least three different Loxosceles species of medical impor-
tance are known in Brazil (Loxosceles intermedia, Loxos-
celes gaucho, Loxosceles laeta) and more than 2000 cases
of envenomation by L. intermedia alone are reported each
year. In the USA, at least six Loxosceles species (including
Loxosceles reclusa: brown recluse) are known to cause nu-
merous incidents (Futrell, 1992).
Loxoscelism can be observed as two well-defined clin-
ical variants: cutaneous loxoscelism and systemic or vis-
cerocutaneous loxoscelism. Pain, edema, and livedoid
plaque, which develops later into a necrotic scar, are the
predominant local manifestations in cutaneous loxoscelism,
occurring in around 83.3% of the cases. In viscerocutane-
ous loxoscelism, hematuria and hemoglobinuria are always
observed, whereas intravascular hemolysis and coagula-
tion, sometimes accompanied by thrombocytopenia and
renal failure, occur in approximately 16% of the victims
(Futrell, 1992; Schenone et al, 1998).
The site of envenomation, which initially causes only mi-
nor discomfort, begins as an enlarging area of erythema and
edema. A centrally located necrotic ulcer often forms 8–24 h
following envenomation (Atkins et al, 1958; Wasserman and
Anderson, 1983–1984). Extensive tissue destruction occurs
and the ulcer may take many months to heal and in some
cases may require debridement or skin grafting. The lesions
are remarkable considering that Loxosceles spiders emit
only a few tenths of microliters of venom, containing no
more than 30 mg of protein.
We have recently purified, characterized, cloned, and
expressed the toxins from L. intermedia venom that are re-
sponsible for all the local and systemic effects induced by
whole venom (Tambourgi et al, 1995, 1998, 2004). Two
highly homologous proteins, termed P1 and P2, with Mr 35
kDa were shown to be endowed with sphingomyelinase
(SMase) activity, were both able to induce dermonecrosis in
rabbits, and rendered human erythrocytes susceptible to
lysis by complement (C) (Tambourgi et al, 1998, 2000, 2004).
The mechanism of pathogenesis of Loxosceles venom
lesion is not clear. Studies of Smith and Micks (1970) sug-
gested the dependence on polymorphonuclear leukocytes
(PMN) in the development of dermonecrosis. In rabbits, a
single intravenous administration of nitrogen mustard inhib-
Abbreviations: C6 def, C6 deficient; CoVF, cobra venom factor;
MAC, membrane attack complex of complement; MMP, matrix
metalloproteinase; PBS, phosphate-buffered saline; PMN, poly-
morphonuclear leukocytes; SMase, sphingomyelinase
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ited early leukocyte infiltration and hemorrhage and the de-
velopment of edema was delayed until the reappearance of
circulating PMN. Depletion of complement in guinea-pigs by
parenteral administration of zymosan or aggregated human
g-globulin resulted in inhibition of leukocyte infiltration and
hemorrhage, and in a marked reduction of edema. Sun-
derko¨tter et al (2001) demonstrated that g irradiation deple-
tion of PMN in mice prevented vessel damage induced
by the injection of Loxosceles venom, suggesting that the
damage is provoked by leukocyte infiltration. Deposition of
complement component C3 was detected around blood
vessels 1–2 h after Loxosceles injection, including in the leu-
kocyte-depleted mice. Depletion of complement by cobra
venom factor (CoVF) could only delay, but not inhibit, the
Loxosceles venom-induced vessels damage in this model.
Paradoxically, in vitro activation of isolated human PMN was
inhibited by Loxosceles venom (Majeski et al, 1977; Bab-
cock et al, 1986). These results suggest important roles for
PMN and complement in the pathogenesis of cutaneous
loxoscelism but also suggest that other factors are involved.
Activation of complement pathways results in the pro-
duction of C5a anaphylatoxin, which is a powerful chemo-
attractant for macrophages and neutrophils and can directly
activate these cells to secrete inflammatory mediators (Em-
ber et al, 1998). The membrane attack complex of comple-
ment (MAC) of complement is also implicated in many
inflammatory conditions, not so much because it may kill
cells, but rather because it causes cell activation resulting in
secretion of chemokines, inflammatory mediators, or ex-
pression of adhesion molecules (Kilgore et al, 1998). Pre-
vious studies investigating the role of C in Loxosceles-
induced dermonecrosis did not investigate the roles of C5a
and the MAC in this process.
Cutaneous loxoscelism is characterized by the appear-
ance of tissue destruction around the bite, resulting in ul-
ceration and the healing of which often requires months.
Although extracellular proteolysis is a prerequisite for nor-
mal wound healing, uncontrolled proteolytic tissue destruc-
tion appears to be a pathogenic factor in non-healing
wounds, in which matrix metalloproteinases (MMP), a family
of extracellular matrix-degrading enzymes, play an impor-
tant role (Sternlicht et al, 2000).
Although the characteristic Loxosceles venom-induced
human skin lesion can be readily produced in experimental
animal models, the cellular and molecular mechanisms that
contribute to lesion development are incompletely defined.
The aim of our study was to investigate the role of com-
plement components C5a and the MAC in a rabbit model
of cutaneous loxoscelism. Furthermore, we also aimed to
investigate the role of Loxosceles venom SMase and
the involvement of endogenous metalloproteinases in this
process. Understanding the molecular mechanisms of
action of Loxosceles venom will aid in the development
of therapies to alleviate the clinical symptoms of spider
envenomation.
Results
Loxoscelic skin lesion Histopathological analysis of rab-
bit skin 24 h after intradermal (i.d.) Loxosceles venom in-
jection showed a normal epidermis, dissociation of the
collagen fibers due to the edema and intense neutrophil
infiltration deep in the dermis (Fig 1B/b), degeneration of
muscle fibers, and discrete neutrophil infiltration in the
muscle layer (Fig 1B).
The histopathological pattern induced by total venom
(Fig 1B) could be reproduced by i.d. injection of purified (Fig
1C) or recombinant SMase P1 (Fig 1D). Neutrophil infiltra-
tion, however, was more widespread in the deep dermis
(Figs 1C/c and D/d), whereas in the smooth muscle cell
layer of the purified P1-injected animals the neutrophil in-
filtration was more intense (Fig 1C). Although statistical
analysis showed a significant difference in the number of
PMN cells in the dermis of phosphate-buffered saline (PBS)
and venom- or toxin-injected animals, no differences were
detected in the number of neutrophils in the dermis of
venom-, SMase P1-, or recombinant SMase P1-induced
lesions (Fig 2A).
Role of complement in the lesion caused by Loxosceles
venom The involvement of the C-system in the develop-
ment of loxoscelic dermonecrotic lesion was evaluated in
C6-deficient (C6-def) rabbits and in CoVF-treated animals.
The hemolytic activity of the serum of CoVF-treated animals
was undetectable 24 h after Loxosceles venom injection
(data not shown). Histopathological analysis showed that in
the C6-def (Fig 1E/e) and in CoVF-treated animals (Fig 1F/f),
the neutrophil infiltration induced by L. intermedia venom
was significantly reduced (po0.001) compared with venom-
injected normal animals (Fig 1B/b), the strongest reduction
of neutrophil infiltration being observed in the CoVF-treated
animals (po0.001) (Fig 2B). But although the edema was
reduced (Fig 1E and F) compared with that present in the
skin from normal animals injected with venom (Fig 1B), dis-
sociation of the collagen fibers, degeneration of muscle
fibers, and hemorrhage in the dermis were still observed
(Fig 1E and F). These results suggest that both C5a and the
MAC are involved in the recruitment of the inflammatory
cells to the site of venom injection, but that neutrophil in-
filtration is not the only cause of tissue damage. Cutaneous
neutrophil infiltration in histologic sections is quantified in
Fig 2A and B.
L. intermedia venom induces the expression of gelatin-
ases Gelatinases have been shown to play an important
role in wound formation and repair. To investigate the ex-
pression of gelatinases in loxoscelism, rabbit skin of en-
venomated and control animals was homogenized and
extracts were analyzed for expression of gelatinases by
zymography. Control skin sections showed constitutive ex-
pression of a gelatinase with an Mr of approximately 70 kDa
(Fig 3A). Twenty-four hours after injection of Loxosceles
venom, SMase P1, or recombinant SMase P1 the induction
of the expression of a gelatinase with a Mr of approximately
90 kDa was observed (Fig 3A). The expression of this gel-
atinase induced by L. intermedia venom was partially pre-
vented by CoVF-induced C-depletion, prior to venom
injection (Fig 3B). Skin extracts injected with PBS did not
show expression of this gelatinase (Fig 3A and B).
The molecular weights of the gelatinases resembled
those of gelatinases A and B, also named matrix metal-
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loproteinases (MMP)-2 and -9 (MMP-2: Mr around 70 kDa
and MMP-9: Mr around 90 kDa). To identify the identities of
these gelatinases, purified human MMP-2 and MMP-9 were
run on the same zymography gel as the skin extract of a
venom-injected rabbit. As shown in Fig 3C, the constitu-
tively expressed gelatinase (lane C, lower band) ran with the
same apparent Mr as human MMP-2 (lane 2), whereas the
venom-induced gelatinase (lane C, upper band) ran at a
similar Mr as human MMP-9 (lane 9). Using polyclonal and
monoclonal antibodies (pAb and mAb) against human
MMP-2 and MMP-9 showed that the sheep polyclonal an-
ti-human MMP-2 and the monoclonal anti-human MMP-9
cross-reacted with their rabbit counterparts and specifically
removed these from the skin extracts (Fig 3C), thereby
identifying the constitutively expressed gelatinase as MMP-
2 and the induced gelatinase as MMP-9. The other anti-
bodies used (mAb anti-MMP-2 and pAb anti-MMP-9) did
not appear to cross-react with the rabbit gelatinases.
Expression of gelatinases by rabbit neutrophils and
skin ﬁbroblasts In order to investigate the source of MMP-
9 induced after venom injection, rabbit skin fibroblasts, one
of the main components of the skin, and rabbit neutrophils
were analyzed for expression of gelatinases. Lysates of
rabbit neutrophils contained a major gelatinase with an Mr
around 90 kDa, corresponding to the Mr of MMP-9 (Fig 4A).
This suggests that neutrophils could be a source of MMP-9
in the skin lesion.
Cultured rabbit skin fibroblasts were incubated with
20 mg of Loxosceles venom and the supernatants collected
after 24 and 48 h were analyzed by gelatine zymography.
Figure 4B shows that fibroblasts constitutively secrete large
Figure 1
Loxoscelic skin lesion: analysis of the role of complement in the dermonecrosis. Histological analysis of skin of rabbits injected with 5 mg of
Loxosceles intermedia venom and purified (P1) or recombinant (rec P1) sphingomyelinases. Control sites were injected with an equal volume of
phosphate-buffered saline (PBS). The involvement of the C system in the development of the dermonecrotic lesion was evaluated in C6-deficient
rabbits (C6 def) or in normal animals that were previously injected with cobra venom factor (CoVF) and 18 h later injected with 5 mg of Loxosceles
venom. Panels correspond to the panoramic view of skin sections from rabbits injected with PBS (A), L. intermedia venom (B), purified P1 (C), rec P1
(D), and from C6-def rabbits (E) or CoVF-treated animals (F) injected with L. intermedia venom. Arrows indicate areas of leukocyte infiltration. Panels
a–f show details of the collagenous area of the dermis of the same sections. White bars at the top of each panel indicate 100 mm.
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amounts of MMP-2 and treatment with venom induced an
increase in the expression of both pro-MMP-2 and MMP-2
in the supernatants, suggesting that fibroblasts are a source
of locally produced MMP-2. Also, a small increase in the
secretion of MMP-9 was observed, suggesting that MMP-9
locally synthetized by fibroblasts may also contribute to
MMP-9 found in the skin after envenomation. Venom and
purified and recombinant toxins did not display gelatinolytic
activity (data not shown).
Discussion
Envenomation by Loxosceles spiders is a well-documented
cause of necrotic skin lesions in humans. Although C ac-
tivation and neutrophils have been implicated in the devel-
opment of the lesion (Smith and Micks, 1970; Sunderko¨tter
et al, 2001), the exact mechanism and factors involved in
the initiation and development of dermonecrosis are not
known. Our aim was to investigate the role of the comple-
ment system and of the endogenous metalloproteinases in
the initiation of the pathology of the dermonecrosis.
Histological analysis of skin of rabbits injected with L.
intermedia venom or purified and recombinant SMase
showed a large influx of neutrophils, concomitant with dis-
sociation of the collagen fibers in the dermis. These data
clearly demonstrate that the SMase are the major or unique
toxins responsible for the main symptoms of the cutaneous
form of loxoscelism.
Decomplementation using CoVF largely prevented the
influx of neutrophils. Influx of neutrophils was also reduced
in genetically C6-def rabbits, demonstrating a role for both
C5a and the MAC in the induction of dermonecrosis. The
slight inflammatory infiltration of neutrophils observed in
CoVF-treated rabbits may be due to the action of chemo-
attractant tetrapeptides generated by collagen degradation
(Rice and Banda, 1995). As a therapy for Loxosceles en-
venomation, frequently dapsone treatment is advocated.
Dapsone acts by preventing neutrophil infiltration; however,
there is little clinical evidence that dapsone therapy is ef-
fective (reviewed by Bryant and Pittman, 2003), which is in
agreement with our data that prevention of neutrophil influx
does not prevent tissue destruction.
Figure 2
Determination of the number of neutrophils in the rabbit skin. (A)
Number of neutrophils in the histological skin sections obtained from
rabbits injected with 5 mg of Loxosceles intermedia venom and purified
(P1) or recombinant (rec P1) sphingomyelinases or with buffer. (B) Ne-
utrophil counts determined for sections obtained from normal or C6-
deficient rabbits (C6 def) injected (þ ) or not () with L. intermedia venom
and from normal animals that were previously injected with cobra venom
factor (CoVF) () and 18 h later injected with 5 mg of Loxosceles venom
(þ ). Results are representative of three different experiments and rep-
resented as mean  SD. Statistical analysis showed significant differ-
ences between the mean values of cell counts obtained for sections from
control and experimental groups of rabbits (po0.001).
Figure 3
Loxosceles intermedia venom induces
the expression of matrix metal-
loproteinases (MMP)-9 in rabbit skin.
Gelatinase activity of rabbit skin samples
was analyzed by zymography. (A) Normal
(control), venom (V), P1, or recombinant
sphingomyelinase P1 (rec P1) (5 mg)-in-
jected rabbits; (B) control, C6-deficient
rabbits (C6-def), and cobra venom factor
(CoVF)-treated rabbits injected with 5 mg
of L. intermedia venom (þ ) or with phos-
phate-buffered saline (). Gelatinase ex-
pression is indicated by the arrows; (C)
skin extract of venom-injected rabbit was
incubated with polyclonal (pAb) or mono-
clonal (mAb) anti-MMP-2 or -MMP-9
bound to protein Sepharose G beads or
with beads without antibody (C). Supe-
rnatants were analyzed by zymography
and compared with purified human MMP-
2 (2) and human MMP-9 (9).
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The Loxosceles toxins do not have a direct effect on the
components of the C-system and it is not known how C
becomes activated in the skin after Loxosceles envenom-
ation. We have focused our recent investigations on the
effects of Loxosceles toxins on erythrocytes and nucleated
cells and have found that the toxins induce activation of
membrane-bound metalloproteinases (Tambourgi et al,
2000; van den Berg et al, 2002). In the case of erythro-
cytes, this led to an increased susceptibility to activation of
C via the classical (possibly by inducing loss of membrane
asymmetry; Tambourgi et al, 2002) and the alternative path-
way (because of metalloproteinase-induced cleavage of
glycophorins; Tambourgi et al, 2000). On nucleated cells,
however, this led to a decrease in C-susceptibility (van den
Berg et al, 2002). The exact mechanisms of these events
and the role in the pathology of loxoscelism remain to be
elucidated. The most likely cause of complement activation
in cutaneous loxoscelism is due to tissue destruction and
damaged collagen and muscle fibers may initiate the ac-
tivation of the classical pathway, resulting in C5a formation
and bystander MAC generation. Furthermore, apoptotic and
necrotic cells have also been shown to activate C and could
also contribute to C5a and MAC generation.
Although C depletion could prevent the infiltration of ne-
utrophils in the areas of venom injection to some extent,
hemorrhage and collagen damage were still observed.
Considering the role of MMP in tissue destruction and re-
modelling, we investigated the possible involvement of
these proteases in the development of the necrotic lesion.
Zymography analysis of skin extracts of envenomated an-
imals showed the induction of expression of an endogenous
gelatinase, identified as MMP-9. Although the exact role of
MMP-9 in the development of the venom-induced lesion
remains to be established, it is likely that it plays a role in the
pathology as it has been shown that elevated levels of
MMP-9 play an important role in both acute and chronic
wounds and ulcers (Wysocki et al, 1993; Trengove et al,
1999). Rabbit neutrophils are likely an important source of
MMP-9, not only because they constitutively express this
metalloproteinase and are found in greater number in the
skin of venom-injected animals but also because treatment
of these cells with venom induced an increase of the basal
level of MMP-9. Furthermore, a lower level of MMP-9 was
observed in the skin of CoVF-treated and Loxosceles ven-
om-injected animals, in which only a low level of neutrophil
infiltration was observed. But, MMP-9 levels in C6-def an-
imals were not decreased, despite the decreased influx of
neutrophils, suggesting that local MMP-9 synthesis is also
of importance. Other possible sources of MMP-9 are fib-
roblasts and keratinocytes. Although we were unable to
generate in vitro cultures of rabbit skin keratinocytes, we
show here that cultured rabbit fibroblasts secreted increas-
ing amounts of MMP-9 and MMP-2 upon incubation with
Loxosceles venom. Loxosceles venom also induced a de-
crease of cell viability of rabbit fibroblasts in a concentra-
tion-dependent manner (data not shown). The increase of
the gelatinase expression associated with cell death as a
consequence of venom SMase action may contribute to the
development of skin lesion.
These data show that the C system plays an important
role in the development of cutaneous loxoscelism through
the C5a- and MAC-induced recruitment of neutrophils. Fur-
thermore, Loxosceles SMase-induced expression of MMP-9
is possibly one of the main factors involved in the patho-
genesis of the cutaneous loxoscelism. The discovery of the
involvement of metalloproteinases in the dermonecrosis
induced by Loxosceles venom is novel and of potential ther-
apeutic significance given the availability of metalloproteinase
inhibitor drugs. The mechanism by which the spider toxins
induce expression and activation of MMP, the involvement of
other MMP in the pathology of loxoscelism, and assessment
of potential therapeutic strategies of using MMP inhibitors to
prevent and treat the pathological consequences of spider
envenomation are subjects of further study.
Materials and Methods
Venom L. intermedia Mello-Leita˜o spiders were provided by
‘‘Laborato´rio de Imunoquı´mica, Instituto Butantan, SP, Brazil’’.
The venom was obtained by electrostimulation by the method of
Burcherl (1969), with slight modifications. Briefly, 15–20 V electrical
stimuli were repeatedly applied to the spider sternum and the
venom drops were collected with a micropipette, vacuum dried,
and stored at 201C. Stock solutions were prepared in PBS
(10 mM Na phosphate, 150 mM NaCl, pH 7.2) at 1.0 mg per mL.
Spider SMase puriﬁcation The SMase P1 from L. intermedia
venom was purified by Superose 12 gel filtration followed by re-
verse phase HPLC using a Wide-Pore Butyl C4 column (Pharma-
cia, Uppsala, Sweden) as described (Tambourgi et al, 1998). The
protein content of the samples was evaluated by the Lowry meth-
od (Lowry et al, 1951).
SMase expression Recombinant L. intermedia SMase P1 (ac-
cession number: AY304471) was expressed in Escherichia coli
strain BL21 (DE3) as a fusion protein composed of the mature
SMase with an N-terminal extension containing a 6  histidine tag
(Tambourgi et al, 2004). Recombinant SMase P1 was purified from
the soluble fraction of cell lysates on a Ni (II) Chelating Sepharose
Fast Flow column (Pharmacia). Recombinant proteins were eluted
with the elution buffer (100 mM Tris-HCl pH 8.0; 300 mM NaCl; 0.8
M imidazole) and dialyzed against PBS. The protein content of the
samples was evaluated by the Lowry method (Lowry et al, 1951).
Experimental animals Adult male New Zealand white rabbits and
C6-def rabbits were bred inhouse. The serum of C6-def animals
Figure 4
Loxosceles venom induces the expression of gelatinases in rabbit
fibroblasts and neutrophils. (A) Zymography analysis of neutrophils
cell extracts after treatment with buffer (C) or with 10 mg per mL of
Loxosceles intermedia venom (V). (B) Supernatants of cultured rabbit
fibroblasts, 24 and 48 h after treatment with buffer (C) or 20 mg per mL
of Loxosceles venom (V). Matrix metalloproteinase (MMP)-9 and MMP-
2 expression is indicated by the arrows.
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was devoid of hemolytic activity. The animals were maintained and
used under strict ethical conditions according to the animal welfare
international recommendations.
Dermonecrosis and histological analysis Samples of 200 mL of
L. intermedia venom/toxins in PBS (25 mg per mL) were injected
intradermally (i.d.) in the shaved back of normal or C6-def rabbits.
After 24 h, the animals were euthanized and skin specimens were
obtained for histological examination and zymography. Skin sam-
ples were fixed in 10% buffered formalin solution, and then em-
bedded in paraffin. Tissue sections were stained with hematoxylin
and eosin and examined for the presence of epithelial necrosis,
epithelial slough, dermal infiltrates, hemorrhage, and level of col-
lagen dissociation in the dermis and skin muscle fiber degenera-
tion. For zymography analysis, skin specimens were collected and
stored at 801C prior to analysis.
Administration of CoVF and Loxosceles venom Rabbits were
injected intravenously with 0.5 mg per kg of CoVF in PBS. CoVF was
purified from Naja naja kaoutia venom (Sigma, St. Louis, Missouri)
according to the method described by Vogel and Muller-Eberhard
(1984). Control animals received PBS. All animals were closely ob-
served for signs of distress. After 18 h, 200 mL of L. intermedia
venom in PBS (25 mg per mL) were injected i.d. in the shaved back
of rabbits. Control sites were injected with an equal volume of PBS.
After 24 h, the animals were euthanized and skin specimens were
obtained for histological examination and zymography analysis.
Blood samples drawn to obtain sera were collected without anti-
coagulant from all groups of rabbits before CoVF injection (time 0 h)
and before Loxosceles venom injection (time 18 h), and 24 h after
envenomation (time 42 h). Blood was allowed to clot for 2 h at room
temperature, and serum samples were stored at 801C.
Cell counting Neutrophil quantification was performed in histo-
logical rabbit skin sections by counting the number of cells, iden-
tified by morphological criteria, in five sites of the dermis (18 mm2
each), using the Image Processing and Analysis System and QWin
Plus Y2.8 program from Leica (Leica Microsytems, Cambridge,
UK). The Student’s t test was used to determine the significance of
the differences between the mean values of cell counts obtained
for sections from control and experimental groups of rabbits. The
minimal level of significance was considered as po0.05.
Hemolytic complement activity Sheep erythrocytes were
washed in PBS and a 2% suspension was incubated with an
equal volume of a 1:500 dilution in PBS of rabbit anti-sheep eryth-
rocyte antiserum (Dade-Behring, Deerfield Illinois) for 15 min at
371C. The antibody-sensitized sheep erythrocytes were washed
and resuspended in veronal-buffered saline (VBSþ þ : 10 mM Na
barbitone, 0.15 mM CaCl2, and 0.5 mM MgCl2; pH 7.4) at 2% final
concentration. For each rabbit serum to be tested doubling dilu-
tions in VBSþ þ were made in the wells of a 96-well plate (150 mL
per well), including 0% and 100% lysis wells. The antibody-sen-
sitized sheep erythrocytes (50 mL) were added to each well, and the
plate was incubated for 30 min at 371C. Intact cells were removed
by centrifugation at 305  g at 41C for 5 min. Fifty microliters of
each supernatant were transferred to new 96-well plates contain-
ing 200 mL of water, and the absorbance was measured at 414 nm
as an index of hemolysis. Percentage of haemolysis for each well
and the number of hemolytic sites (Z) for each serum were cal-
culated by standard methods.
Treatment of rabbit ﬁbroblasts with Loxosceles venom Fibro-
blasts were isolated from adult male New Zealand rabbits by
treatment of skin sections, obtained from euthanized normal an-
imals, with 0.25% trypsin in Dulbecco’s modified Eagles’s medium
(DMEM) for 1 h. The cell suspension was filtered over sterile gauze
and cells were washed twice and cultured in DMEM supplemented
with 10% (vol/vol) heat-inactivated (561C, 30 min) fetal bovine
serum (FBS; Gibco-BRL, Gaithersburg, Maryland), 100 IU per mL
penicillin, and 100 IU per mL streptomycin at 371C in humidified air
with 5% CO2. After 48 h of culture, medium containing non-adher-
ent cells and debris was removed and fresh medium was added.
Rabbit fibroblasts were subcultured in 24-well plates. Cells at
50%–70% confluence at passage 5 were maintained overnight in
DMEM without FBS followed by incubation with Loxosceles venom
in DMEM (10 mg venom in 500 mL of medium) at 371C and 5% CO2.
As negative controls, cells were incubated with DMEM alone.
Supernatants from the cultures were recovered and analyzed by
zymography.
Treatment of rabbit neutrophils with Loxosceles venom Rabbit
neutrophils were isolated by dextran sedimentation and Ficoll
density centrifugation. Cells were counted in a Neubauer chamber
(Boeco Germany, Hamburg, Germany), resuspended at 105 cells
per mL in Krebs–Hepes buffer (NaCl 120 mM, Hepes 25 mM, KCl
4.8 mM, KH2PO4 1.2 mM, MgSO4 1.2 mM, CaCl2 1.3 mM; pH 7.4),
and incubated with 20 mg per mL of L. intermedia venom for 30 min
at room temperature. After incubation, cells were washed and cell
pellets (lysed in 250 mL of SDS sample buffer) were analyzed by
gelatine zymography.
Zymography Gelatinase activity in supernatants of fibroblasts,
neutrophil lysates, and homogenized skin samples was analyzed by
zymography (Kleiner and Stetler-Stewensow, 1994). Skin samples
were homogenized in SDS-PAGE sample buffer at 1 g per mL in a
tissue grinder, spun (405  g for 10 min) to pellet debris, the supe-
rnatants were recovered, and 20 mL of each sample was run under
non-reducing conditions on a 10% polyacrylamide gel containing
1% gelatine. The gels were washed twice for 30 min at room tem-
perature in 2.5% Triton X-100, and overnight incubated at 371C in
zymography buffer (50 mM Tris-HCl, 200 mM NaCl, 10 mM CaCl2,
0.05% Brij-35; pH 8.3). Gels were stained in Coomassie Brilliant Blue
solution (40% methanol, 10% acetic acid, and 0.1% Coomassie
Brilliant Blue). To identify the identities of the bands observed after
gelatin zymography, samples of purified human neutrophil MMP-9
(Calbiochem, San Diego, California) and purified human synovial
fibroblast MMP-2 (Calbiochem) were run on the same gel. Immuno-
depletion of skin extracts were carried out as follows: 50 mL Protein
G-sepharose beads (Amersham Biosciences-Buckinghamshire,
UK) were incubated with 5 mg MMP-specific antibodies (sheep an-
ti-human MMP-2 and MMP-9 were from Biogenesis, Brentwood,
NH, USA; monoclonal anti-human MMP-2 and MMP-9 were from
R&D Systems, Minneapolis, MN, USA), followed by incubation with
50 mL of 1/10 diluted skin extract of venom-injected rabbits. After 1
h incubation at room temperature, the beads were spun and the
supernatant was assessed for gelatinolytic activity by zymography.
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